MBX Biosciences

BiotechnologySeries CCarmel, USmbxbio.com

Latest round

Series C

Last raised

Aug 2024

Total raised

$136M

Investors

12

About MBX Biosciences

Based in the US, MBX Biosciences, Inc.Founded in 2019, MBX Biosciences, Inc. is dedicated to advancing therapeutic candidates for endocrine and metabolic disorders. The company is headquartered in Carmel, US.08 mn.MBX Biosciences, Inc. specializes in developing Precision Endocrine Peptide™ (PEP™) therapeutic candidates that focus on treating endocrine and metabolic disorders. The company is advancing a pipeline of peptide therapeutics aimed at improving treatment outcomes in conditions such as hypoparathyroidism and diabetes.MBX Biosciences generates revenue primarily through strategic partnerships and collaborations with pharmaceutical companies and healthcare institutions. Licensing agreements for its PEP™ therapeutics further contribute to revenue, targeting B2B transactions with biotech and healthcare providers.On September 12, 2024, MBX Biosciences, Inc.2 million shares at USD 16 each on the Nasdaq Global Select Market under the ticker symbol "MBX". The company has initiated plans to expand its product offerings and enter new markets, with specific targets in regions like North America and Europe where there is significant demand for endocrine and metabolic disorder therapies.

Who invested in MBX Biosciences

12 investors across 3 rounds

See all investors in MBX Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Aug 15, 2024

    Amount

    $64M

    Investors

    Locked

  2. Series B

    Nov 7, 2022

    Amount

    $47M

    Investors

    Locked

  3. Series A

    Jul 16, 2020

    Amount

    $26M

    Investors

    Locked

Questions about MBX Biosciences

Who invested in MBX Biosciences?

MBX Biosciences has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has MBX Biosciences raised?

MBX Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did MBX Biosciences last raise money?

MBX Biosciences's most recent round on record is a Series C, in Aug 2024.

What does MBX Biosciences do?

Based in the US, MBX Biosciences, Inc.

Where is MBX Biosciences headquartered?

MBX Biosciences is headquartered in Carmel, US.

Which VCs invest in companies like MBX Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at MBX Biosciences's stage. Their profiles are linked below.

Raising like MBX Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.